DE3584341D1
(en)
|
1984-08-24 |
1991-11-14 |
Upjohn Co |
RECOMBINANT DNA COMPOUNDS AND EXPRESSION OF POLYPEPTIDES LIKE TPA.
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
US4751180A
(en)
|
1985-03-28 |
1988-06-14 |
Chiron Corporation |
Expression using fused genes providing for protein product
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US4935233A
(en)
|
1985-12-02 |
1990-06-19 |
G. D. Searle And Company |
Covalently linked polypeptide cell modulators
|
US5135855A
(en)
|
1986-09-03 |
1992-08-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Rapid, versatile and simple system for expressing genes in eukaryotic cells
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
DE10399031I1
(en)
|
1987-08-28 |
2004-01-29 |
Health Research Inc |
Recombinant viruses.
|
US5849563A
(en)
|
1989-02-24 |
1998-12-15 |
The University Of Medecine And Dentistry Of New Jersey |
Eukaryotes expressing single stranded hybrid molecules
|
US5780269A
(en)
|
1989-02-24 |
1998-07-14 |
The University Of Medicine And Denistry Of New Jersey |
Hybrid molecules
|
US5405775A
(en)
|
1989-02-24 |
1995-04-11 |
The University Of Medicine And Dentistry Of New Jersey |
Retrons coding for hybrid DNA/RNA molecules
|
US5320958A
(en)
|
1989-02-24 |
1994-06-14 |
University Of Medicine And Dentistry Of New Jersey |
Isolated bacterial reverse transcriptase
|
US5436141A
(en)
|
1989-02-24 |
1995-07-25 |
University Of Medicine And Dentistry Of New Jersey |
Method for synthesizing stable single-stranded CDNA in eukaryotes by means of a bacterial retron and products
|
US6017737A
(en)
|
1989-02-24 |
2000-01-25 |
The University Of Medicine And Denistry Of New Jersey |
E. coli msDNA synthesizing system, products and uses
|
US6867195B1
(en)
|
1989-03-21 |
2005-03-15 |
Vical Incorporated |
Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
|
FR2658432B1
(en)
|
1990-02-22 |
1994-07-01 |
Medgenix Group Sa |
MICROSPHERES FOR THE CONTROLLED RELEASE OF WATER-SOLUBLE SUBSTANCES AND PREPARATION METHOD.
|
AU8200191A
(en)
|
1990-07-09 |
1992-02-04 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
High efficiency packaging of mutant adeno-associated virus using amber suppressions
|
MY109299A
(en)
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
DE69233013T2
(en)
|
1991-08-20 |
2004-03-04 |
The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer |
ADENOVIRUS MEDIATED GENTRANSFER INTO THE GASTROINTESTINAL TRACT
|
US5436150A
(en)
|
1992-04-03 |
1995-07-25 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
|
US5591601A
(en)
|
1993-05-14 |
1997-01-07 |
Ohio University Edison Animal Biotechnology Institute |
DNA polymerase gene expression system utilizing an RNA polymerase co-delivered with the gene expression vector system
|
US5834441A
(en)
|
1993-09-13 |
1998-11-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Adeno-associated viral (AAV) liposomes and methods related thereto
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
WO1995025809A1
(en)
|
1994-03-23 |
1995-09-28 |
Ohio University |
Compacted nucleic acids and their delivery to cells
|
US5844107A
(en)
|
1994-03-23 |
1998-12-01 |
Case Western Reserve University |
Compacted nucleic acids and their delivery to cells
|
US6077835A
(en)
|
1994-03-23 |
2000-06-20 |
Case Western Reserve University |
Delivery of compacted nucleic acid to cells
|
US5972901A
(en)
|
1994-03-23 |
1999-10-26 |
Case Western Reserve University |
Serpin enzyme complex receptor--mediated gene transfer
|
US5676950A
(en)
|
1994-10-28 |
1997-10-14 |
University Of Florida |
Enterically administered recombinant poxvirus vaccines
|
AU4594996A
(en)
|
1994-11-30 |
1996-06-19 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
WO1996039154A1
(en)
|
1995-06-06 |
1996-12-12 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having phosphorothioate linkages of high chiral purity
|
US5985662A
(en)
|
1995-07-13 |
1999-11-16 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of hepatitis B virus replication
|
US5965542A
(en)
|
1997-03-18 |
1999-10-12 |
Inex Pharmaceuticals Corp. |
Use of temperature to control the size of cationic liposome/plasmid DNA complexes
|
US6410328B1
(en)
|
1998-02-03 |
2002-06-25 |
Protiva Biotherapeutics Inc. |
Sensitizing cells to compounds using lipid-mediated gene and compound delivery
|
AU749881B2
(en)
|
1998-02-03 |
2002-07-04 |
Inex Pharmaceuticals Corporation |
Systemic delivery of serum stable plasmid lipid particles for cancer therapy
|
US6140081A
(en)
|
1998-10-16 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger binding domains for GNN
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
US7013219B2
(en)
|
1999-01-12 |
2006-03-14 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
US20030104526A1
(en)
|
1999-03-24 |
2003-06-05 |
Qiang Liu |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
ATE463578T1
(en)
|
1999-04-14 |
2010-04-15 |
Novartis Vaccines & Diagnostic |
COMPOSITIONS AND METHODS FOR TRIGGERING AN IMMUNE RESPONSE BASED ON ALPHAVIRUS VECTOR SYSTEMS
|
US6211140B1
(en)
|
1999-07-26 |
2001-04-03 |
The Procter & Gamble Company |
Cationic charge boosting systems
|
US6780590B2
(en)
|
1999-09-14 |
2004-08-24 |
Sangamo Biosciences, Inc. |
Gene identification
|
JP2003514564A
(en)
|
1999-11-24 |
2003-04-22 |
エムシーエス マイクロ キャリア システムズ ゲーエムベーハー |
Polypeptides Containing Multimers of Nuclear Localization Signals or Protein Transduction Regions, and Uses Thereof for Transferring Molecules Into Cells
|
AU776576B2
(en)
|
1999-12-06 |
2004-09-16 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
DE60143192D1
(en)
|
2000-02-08 |
2010-11-18 |
Sangamo Biosciences Inc |
CELLS FOR THE DISCOVERY OF MEDICAMENTS
|
AU2001249380A1
(en)
|
2000-03-22 |
2001-11-07 |
Chiron Corporation |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
|
DE60126483T2
(en)
|
2000-04-28 |
2007-12-06 |
Sangamo BioSciences, Inc., Richmond |
Targeted modification of the chromatin structure
|
US20020042388A1
(en)
|
2001-05-01 |
2002-04-11 |
Cooper Mark J. |
Lyophilizable and enhanced compacted nucleic acids
|
US6919204B2
(en)
|
2000-09-29 |
2005-07-19 |
Sangamo Biosciences, Inc. |
Modulation of gene expression using localization domains
|
AU2002213431A1
(en)
|
2000-09-29 |
2002-04-08 |
Sangamo Biosciences, Inc. |
Modulation of gene expression using localization domains
|
US20020150626A1
(en)
|
2000-10-16 |
2002-10-17 |
Kohane Daniel S. |
Lipid-protein-sugar particles for delivery of nucleic acids
|
AU2002305914A1
(en)
|
2001-01-12 |
2002-10-21 |
Chiron Corporation |
Nucleic acid mucosal immunization
|
US7273923B2
(en)
|
2001-01-22 |
2007-09-25 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
US7476500B1
(en)
|
2001-03-19 |
2009-01-13 |
President And Fellows Of Harvard College |
In vivo selection system for enzyme activity
|
CA2445947A1
(en)
|
2001-04-30 |
2002-11-07 |
Targeted Genetics Corporation |
Lipid-comprising drug delivery complexes and methods for their production
|
AU2002303330B2
(en)
|
2001-05-31 |
2008-07-24 |
Novartis Vaccines And Diagnostics, Inc. |
Chimeric alphavirus replicon particles
|
WO2003027247A2
(en)
|
2001-09-24 |
2003-04-03 |
Sangamo Biosciences, Inc. |
Modulation of stem cells using zinc finger proteins
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
ATE347593T1
(en)
|
2002-01-23 |
2006-12-15 |
Univ Utah Res Found |
TARGETED CHROMOSOMAL MUTAGENESIS WITH ZINC FINGER NUCLEASES
|
US20060078552A1
(en)
|
2002-03-15 |
2006-04-13 |
Sylvain Arnould |
Hybrid and single chain meganucleases and use thereof
|
US20100151556A1
(en)
|
2002-03-15 |
2010-06-17 |
Cellectis |
Hybrid and single chain meganucleases and use thereof
|
WO2003080809A2
(en)
|
2002-03-21 |
2003-10-02 |
Sangamo Biosciences, Inc. |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
US7947873B2
(en)
|
2002-04-17 |
2011-05-24 |
Sangamo Biosciences, Inc. |
Compositions and methods for regulation of plant gamma-tocopherol methyltransferase
|
ATE485031T1
(en)
|
2002-06-28 |
2010-11-15 |
Protiva Biotherapeutics Inc |
METHOD AND DEVICE FOR PRODUCING LIPOSOMES
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
US20040235002A1
(en)
|
2002-09-20 |
2004-11-25 |
Sangamo Biosciences, Inc. |
Multiplex screening assays
|
JP4966006B2
(en)
|
2003-01-28 |
2012-07-04 |
セレクティス |
Custom-made meganucleases and their use
|
ES2559828T3
(en)
|
2003-07-16 |
2016-02-16 |
Protiva Biotherapeutics Inc. |
RNA interference encapsulated in lipids
|
US6927663B2
(en)
|
2003-07-23 |
2005-08-09 |
Cardiac Pacemakers, Inc. |
Flyback transformer wire attach method to printed circuit board
|
NZ581166A
(en)
|
2003-09-15 |
2011-06-30 |
Protiva Biotherapeutics Inc |
Polyethyleneglycol-modified lipid compounds and uses thereof
|
US20050183161A1
(en)
|
2003-10-14 |
2005-08-18 |
Athenix Corporation |
AXMI-010, a delta-endotoxin gene and methods for its use
|
US7629504B2
(en)
|
2003-12-22 |
2009-12-08 |
Pioneer Hi-Bred International, Inc. |
Bacillus thuringiensis cry9 nucleic acids
|
AU2005232665B2
(en)
|
2004-04-08 |
2010-05-13 |
Sangamo Therapeutics, Inc. |
Methods and compositions for treating neuropathic and neurodegenerative conditions
|
EP1737498A2
(en)
|
2004-04-08 |
2007-01-03 |
Sangamo Biosciences Inc. |
Zinc finger proteins for treatment of neuropathic pain
|
EP1591521A1
(en)
|
2004-04-30 |
2005-11-02 |
Cellectis |
I-Dmo I derivatives with enhanced activity at 37 degrees C and use thereof
|
JP4764426B2
(en)
|
2004-06-07 |
2011-09-07 |
プロチバ バイオセラピューティクス インコーポレイティッド |
Cationic lipids and methods of use
|
ATE536418T1
(en)
|
2004-06-07 |
2011-12-15 |
Protiva Biotherapeutics Inc |
LIPID ENCAPSULATED INTERFERENCE RNA
|
US20060063231A1
(en)
|
2004-09-16 |
2006-03-23 |
Sangamo Biosciences, Inc. |
Compositions and methods for protein production
|
JP4988606B2
(en)
|
2005-02-28 |
2012-08-01 |
サンガモ バイオサイエンシズ インコーポレイテッド |
Anti-angiogenic methods and compositions
|
AU2006224248B2
(en)
|
2005-03-15 |
2011-01-06 |
Cellectis |
I-Crei meganuclease variants with modified specificity, method of preparation and uses thereof
|
JP4654806B2
(en)
|
2005-07-15 |
2011-03-23 |
ソニー株式会社 |
Information processing apparatus, information recording medium manufacturing apparatus, information recording medium and method, and computer program
|
CN101273141B
(en)
|
2005-07-26 |
2013-03-27 |
桑格摩生物科学股份有限公司 |
Targeted integration and expression of exogenous nucleic acid sequences
|
CN101267805A
(en)
|
2005-07-27 |
2008-09-17 |
普洛体维生物治疗公司 |
Systems and methods for manufacturing liposomes
|
EP2341135A3
(en)
|
2005-10-18 |
2011-10-12 |
Precision Biosciences |
Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
|
WO2007049095A1
(en)
|
2005-10-25 |
2007-05-03 |
Cellectis |
Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
|
US20090305977A1
(en)
|
2006-02-09 |
2009-12-10 |
Sangamo Bioscience, Inc. |
Method for treating peripheral arterial disease with zinc finger proteins
|
WO2007093836A1
(en)
|
2006-02-13 |
2007-08-23 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
|
WO2007123636A2
(en)
|
2006-03-27 |
2007-11-01 |
Children's Hospital & Regional Medical Center |
Compositions and methods comprising the use of cell surface displayed homing endonucleases
|
JP5551432B2
(en)
|
2006-05-25 |
2014-07-16 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
Methods and compositions for gene inactivation
|
CA2660485C
(en)
|
2006-08-11 |
2016-04-12 |
Sangamo Biosciences, Inc. |
Zinc finger nuclease-mediated homologous recombination
|
WO2008059382A2
(en)
|
2006-11-14 |
2008-05-22 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
|
WO2008093152A1
(en)
|
2007-02-01 |
2008-08-07 |
Cellectis |
Obligate heterodimer meganucleases and uses thereof
|
EP2126066B1
(en)
|
2007-02-19 |
2013-05-01 |
Cellectis |
Laglidadg homing endonuclease variants having novel substrate specificity and use thereof
|
WO2008153742A2
(en)
|
2007-05-23 |
2008-12-18 |
Sangamo Biosciences, Inc. |
Methods and compositions for increased transgene expression
|
WO2008149176A1
(en)
|
2007-06-06 |
2008-12-11 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof
|
EP2770052A1
(en)
|
2007-06-06 |
2014-08-27 |
Cellectis |
Method for enhancing the cleavage activity of I-CreI derived meganucleases
|
WO2009013559A1
(en)
|
2007-07-23 |
2009-01-29 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
|
WO2009019528A1
(en)
|
2007-08-03 |
2009-02-12 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
|
WO2009068937A1
(en)
|
2007-11-28 |
2009-06-04 |
Cellectis |
I-msoi homing endonuclease variants having novel substrate specificity and use thereof
|
JP5749494B2
(en)
|
2008-01-02 |
2015-07-15 |
テクミラ ファーマシューティカルズ コーポレイション |
Improved compositions and methods for delivery of nucleic acids
|
DK2279254T3
(en)
|
2008-04-15 |
2017-09-18 |
Protiva Biotherapeutics Inc |
PRESENT UNKNOWN LIPID FORMS FOR NUCLEIC ACID ADMINISTRATION
|
WO2009146179A1
(en)
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
WO2010001189A1
(en)
|
2008-07-03 |
2010-01-07 |
Cellectis |
The crystal structure of i-dmoi in complex with its dna target, improved chimeric meganucleases and uses thereof
|
EP2313498B1
(en)
|
2008-07-14 |
2017-03-15 |
Precision Biosciences, Inc. |
Recognition sequences for i-crei-derived meganucleases and uses thereof
|
WO2010026443A1
(en)
|
2008-09-08 |
2010-03-11 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a glutamine synthetase gene and uses thereof
|
EP2180058A1
(en)
|
2008-10-23 |
2010-04-28 |
Cellectis |
Meganuclease recombination system
|
JP5756016B2
(en)
|
2008-10-29 |
2015-07-29 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
Method and composition for inactivating expression of glutamine synthetase gene
|
EP2355851B1
(en)
|
2008-11-10 |
2018-04-04 |
Arbutus Biopharma Corporation |
Novel lipids and compositions for the delivery of therapeutics
|
CA2745031C
(en)
|
2008-12-04 |
2018-08-14 |
Sangamo Biosciences, Inc. |
Genome editing in rats using zinc-finger nucleases
|
WO2010122367A2
(en)
|
2009-04-21 |
2010-10-28 |
Cellectis |
Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
|
US8772008B2
(en)
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
WO2010136981A2
(en)
|
2009-05-26 |
2010-12-02 |
Cellectis |
Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
|
EP2449135B1
(en)
|
2009-06-30 |
2016-01-06 |
Sangamo BioSciences, Inc. |
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
|
ES2613498T3
(en)
|
2009-07-01 |
2017-05-24 |
Protiva Biotherapeutics Inc. |
New lipid formulations for the delivery of therapeutic agents to solid tumors
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
US8575425B2
(en)
|
2009-07-02 |
2013-11-05 |
Athenix Corporation |
AXMI-205 pesticidal gene and methods for its use
|
WO2011007193A1
(en)
|
2009-07-17 |
2011-01-20 |
Cellectis |
Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting
|
EP2480659A2
(en)
|
2009-09-24 |
2012-08-01 |
Cellectis |
Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
|
US20130022649A1
(en)
|
2009-12-01 |
2013-01-24 |
Protiva Biotherapeutics, Inc. |
Snalp formulations containing antioxidants
|
CA3044884A1
(en)
|
2009-12-07 |
2011-06-16 |
Arbutus Biopharma Corporation |
Compositions for nucleic acid delivery
|
WO2011075656A1
(en)
|
2009-12-18 |
2011-06-23 |
The University Of British Columbia |
Methods and compositions for delivery of nucleic acids
|
WO2011090965A1
(en)
|
2010-01-22 |
2011-07-28 |
Merck Sharp & Dohme Corp. |
Novel cationic lipids for oligonucleotide delivery
|
WO2011101696A1
(en)
|
2010-02-18 |
2011-08-25 |
Cellectis |
Improved meganuclease recombination system
|
JP2013520190A
(en)
|
2010-02-26 |
2013-06-06 |
セレクティス |
Use of endonuclease for transgene insertion into the Safe Harbor locus
|
US9567573B2
(en)
|
2010-04-26 |
2017-02-14 |
Sangamo Biosciences, Inc. |
Genome editing of a Rosa locus using nucleases
|
CN102884041B
(en)
|
2010-04-28 |
2015-04-15 |
协和发酵麒麟株式会社 |
Cationic lipid
|
US8772453B2
(en)
|
2010-05-03 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Compositions for linking zinc finger modules
|
US20130123338A1
(en)
|
2010-05-12 |
2013-05-16 |
Protiva Biotherapeutics, Inc. |
Novel cationic lipids and methods of use thereof
|
US20130145487A1
(en)
|
2010-05-12 |
2013-06-06 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
|
US20130183282A1
(en)
|
2010-05-12 |
2013-07-18 |
Cellectis |
Meganuclease variants cleaving a DNA target sequence from the rhodopsin gene and uses thereof
|
ES2634087T3
(en)
|
2010-06-03 |
2017-09-26 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the administration of active agents
|
CA2802822A1
(en)
|
2010-06-15 |
2012-01-05 |
Cellectis |
Method for improving cleavage of dna by endonuclease sensitive to methylation
|
CA2804249A1
(en)
|
2010-07-07 |
2012-01-12 |
Cellectis |
Meganucleases variants cleaving a dna target sequence in the nanog gene and uses thereof
|
WO2012016184A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
MX2013001742A
(en)
|
2010-08-19 |
2013-05-14 |
Pioneer Hi Bred Int |
Novel bacillus thuringiensis gene with lepidopteran activity
|
US7919605B1
(en)
|
2010-08-30 |
2011-04-05 |
Amyris, Inc. |
Nucleic acids, compositions and methods for the excision of target nucleic acids
|
US8466122B2
(en)
|
2010-09-17 |
2013-06-18 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
KR20120052656A
(en)
|
2010-11-16 |
2012-05-24 |
주식회사 에피밸리 |
Iii nitride semiconductor light emitting device
|
US20120252122A1
(en)
|
2011-01-05 |
2012-10-04 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing production of induced pluripotent stem cells (ipscs)
|
EP2663548B1
(en)
|
2011-01-11 |
2017-04-05 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
US20120204282A1
(en)
|
2011-02-04 |
2012-08-09 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating occular disorders
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
WO2013009525A1
(en)
|
2011-07-08 |
2013-01-17 |
Cellectis S.A. |
Method for increasing the efficiency of double-strand break-induced mutagenssis
|
WO2013016058A1
(en)
|
2011-07-22 |
2013-01-31 |
Merck Sharp & Dohme Corp. |
Novel bis-nitrogen containing cationic lipids for oligonucleotide delivery
|
KR102209330B1
(en)
|
2011-09-21 |
2021-01-29 |
상가모 테라퓨틱스, 인코포레이티드 |
Methods and compositions for refulation of transgene expression
|
EP2760477B1
(en)
|
2011-09-27 |
2018-08-08 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted pegylated lipids
|
US8762704B2
(en)
|
2011-09-29 |
2014-06-24 |
Apple Inc. |
Customized content for electronic devices
|
EP3988537A1
(en)
|
2011-12-07 |
2022-04-27 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
WO2013086373A1
(en)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Lipids for the delivery of active agents
|
US9463247B2
(en)
|
2011-12-07 |
2016-10-11 |
Alnylam Pharmaceuticals, Inc. |
Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents
|
RS63244B1
(en)
|
2011-12-16 |
2022-06-30 |
Modernatx Inc |
Modified mrna compositions
|
UA118014C2
(en)
|
2012-05-25 |
2018-11-12 |
Те Ріджентс Оф Те Юніверсіті Оф Каліфорнія |
METHOD OF METHOD MODIFICATION
|
WO2014008334A1
(en)
|
2012-07-06 |
2014-01-09 |
Alnylam Pharmaceuticals, Inc. |
Stable non-aggregating nucleic acid lipid particle formulations
|
EP2872154B1
(en)
|
2012-07-11 |
2017-05-31 |
Sangamo BioSciences, Inc. |
Methods and compositions for delivery of biologics
|
WO2014093694A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
DK2921557T3
(en)
|
2012-12-12 |
2016-11-07 |
Broad Inst Inc |
Design of systems, methods and optimized sequence manipulation guide compositions
|
DK2931898T3
(en)
|
2012-12-12 |
2016-06-20 |
Massachusetts Inst Technology |
CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS
|
SG10201912327SA
(en)
|
2012-12-12 |
2020-02-27 |
Broad Inst Inc |
Engineering and Optimization of Improved Systems, Methods and Enzyme Compositions for Sequence Manipulation
|
RU2721275C2
(en)
|
2012-12-12 |
2020-05-18 |
Те Брод Инститьют, Инк. |
Delivery, construction and optimization of systems, methods and compositions for sequence manipulation and use in therapy
|
EP2931899A1
(en)
|
2012-12-12 |
2015-10-21 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
|
CA2894668A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas systems and methods for altering expression of gene products in eukaryotic cells
|
PL2921557T3
(en)
|
2012-12-12 |
2017-03-31 |
Broad Inst Inc |
Engineering of systems, methods and optimized guide compositions for sequence manipulation
|
WO2014093736A1
(en)
|
2012-12-13 |
2014-06-19 |
Dow Agrosciences Llc |
Dna detection methods for site specific nuclease activity
|
ES2741951T3
(en)
|
2012-12-17 |
2020-02-12 |
Harvard College |
Genetic engineering modification of the human genome guided by RNA
|
WO2014130955A1
(en)
|
2013-02-25 |
2014-08-28 |
Sangamo Biosciences, Inc. |
Methods and compositions for enhancing nuclease-mediated gene disruption
|
AU2014235794A1
(en)
|
2013-03-14 |
2015-10-22 |
Caribou Biosciences, Inc. |
Compositions and methods of nucleic acid-targeting nucleic acids
|
CA3161835A1
(en)
|
2013-03-15 |
2014-09-25 |
The General Hospital Corporation |
Rna-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
US11332719B2
(en)
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
US20140273230A1
(en)
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
EP2970997A1
(en)
|
2013-03-15 |
2016-01-20 |
Regents of the University of Minnesota |
Engineering plant genomes using crispr/cas systems
|
US20140349400A1
(en)
|
2013-03-15 |
2014-11-27 |
Massachusetts Institute Of Technology |
Programmable Modification of DNA
|
US20140364333A1
(en)
|
2013-03-15 |
2014-12-11 |
President And Fellows Of Harvard College |
Methods for Live Imaging of Cells
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
RU2723130C2
(en)
|
2013-04-05 |
2020-06-08 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Methods and compositions for embedding an exogenous sequence into a plant genome
|
ES2699578T3
(en)
|
2013-04-16 |
2019-02-11 |
Regeneron Pharma |
Directed modification of the rat genome
|
JP2016518142A
(en)
|
2013-05-10 |
2016-06-23 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
Delivery methods and compositions for nuclease-mediated genomic gene manipulation
|
US20140349405A1
(en)
|
2013-05-22 |
2014-11-27 |
Wisconsin Alumni Research Foundation |
Rna-directed dna cleavage and gene editing by cas9 enzyme from neisseria meningitidis
|
US11414695B2
(en)
|
2013-05-29 |
2022-08-16 |
Agilent Technologies, Inc. |
Nucleic acid enrichment using Cas9
|
WO2014191527A1
(en)
|
2013-05-31 |
2014-12-04 |
Cellectis |
A laglidadg homing endonuclease cleaving the t cell receptor alpha gene and uses thereof
|
US10006052B2
(en)
|
2013-05-31 |
2018-06-26 |
Cellectis |
Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof
|
US9267135B2
(en)
|
2013-06-04 |
2016-02-23 |
President And Fellows Of Harvard College |
RNA-guided transcriptional regulation
|
EP3988654A1
(en)
|
2013-08-28 |
2022-04-27 |
Sangamo Therapeutics, Inc. |
Compositions for linking dna-binding domains and cleavage domains
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
EP3929279A1
(en)
|
2014-03-18 |
2021-12-29 |
Sangamo Therapeutics, Inc. |
Methods and compositions for regulation of zinc finger protein expression
|
SI3766916T1
(en)
|
2014-06-25 |
2023-01-31 |
Acuitas Therapeutics Inc. |
Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
US9816074B2
(en)
|
2014-07-25 |
2017-11-14 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
|
WO2016069912A1
(en)
|
2014-10-29 |
2016-05-06 |
Massachusetts Eye And Ear Infirmary |
Efficient delivery of therapeutic molecules in vitro and in vivo
|
WO2016106236A1
(en)
|
2014-12-23 |
2016-06-30 |
The Broad Institute Inc. |
Rna-targeting system
|
MX2017014446A
(en)
|
2015-05-12 |
2018-06-13 |
Sangamo Therapeutics Inc |
Nuclease-mediated regulation of gene expression.
|
WO2016189532A1
(en)
|
2015-05-26 |
2016-12-01 |
Ramot At Tel-Aviv University Ltd. |
Targeted lipid particles for systemic delivery of nucleic acid molecules to leukocytes
|
WO2017004143A1
(en)
|
2015-06-29 |
2017-01-05 |
Acuitas Therapeutics Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
RS63030B1
(en)
|
2015-09-17 |
2022-04-29 |
Modernatx Inc |
Compounds and compositions for intracellular delivery of therapeutic agents
|
US20190225955A1
(en)
|
2015-10-23 |
2019-07-25 |
President And Fellows Of Harvard College |
Evolved cas9 proteins for gene editing
|
EP4212510A1
(en)
|
2015-10-28 |
2023-07-19 |
Acuitas Therapeutics Inc. |
Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
EP3380622A4
(en)
|
2015-11-23 |
2019-08-07 |
Sangamo Therapeutics, Inc. |
Methods and compositions for engineering immunity
|
EP3397613A1
(en)
|
2015-12-30 |
2018-11-07 |
Acuitas Therapeutics Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
JP7012650B2
(en)
|
2016-02-02 |
2022-01-28 |
サンガモ セラピューティクス, インコーポレイテッド |
Composition for linking DNA binding domain and cleavage domain
|
MX2018016389A
(en)
|
2016-06-30 |
2019-08-16 |
Arbutus Biopharma Corp |
Compositions and methods for delivering messenger rna.
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
SG11201903230QA
(en)
|
2016-10-11 |
2019-05-30 |
Bluebird Bio Inc |
TCRa HOMING ENDONUCLEASE VARIANTS
|
EP3668833A1
(en)
|
2017-08-16 |
2020-06-24 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
WO2019135816A2
(en)
|
2017-10-23 |
2019-07-11 |
The Broad Institute, Inc. |
Novel nucleic acid modifiers
|
WO2019089828A1
(en)
|
2017-10-31 |
2019-05-09 |
Acuitas Therapeutics, Inc. |
Lamellar lipid nanoparticles
|
WO2019126558A1
(en)
|
2017-12-20 |
2019-06-27 |
Bluebird Bio, Inc. |
Ahr homing endonuclease variants, compositions, and methods of use
|
US20190314291A1
(en)
|
2018-01-30 |
2019-10-17 |
Modernatx, Inc. |
Compositions and methods for delivery of agents to immune cells
|
CA3101478A1
(en)
|
2018-05-30 |
2019-12-05 |
Translate Bio, Inc. |
Vitamin cationic lipids
|
JP2021528426A
(en)
|
2018-06-19 |
2021-10-21 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
Lipid nanoparticle composition for delivery of mRNA and long nucleic acids
|
KR20210149686A
(en)
|
2018-12-27 |
2021-12-09 |
라이프에디트 테라퓨틱스, 인크. |
Polypeptides useful for gene editing and methods of use
|
MX2021011426A
(en)
|
2019-03-19 |
2022-03-11 |
Broad Inst Inc |
Methods and compositions for editing nucleotide sequences.
|
WO2020210751A1
(en)
|
2019-04-12 |
2020-10-15 |
The Broad Institute, Inc. |
System for genome editing
|
BR112022004759A2
(en)
|
2019-09-19 |
2022-06-21 |
Modernatx Inc |
Branched tail lipid compositions and compounds for intracellular delivery of therapeutic agents
|
AU2020366519A1
(en)
|
2019-10-18 |
2022-05-26 |
The Trustees Of The University Of Pennsylvania |
Lipid nanoparticles and formulations thereof for CAR mRNA delivery
|
EP4132576A1
(en)
|
2020-04-09 |
2023-02-15 |
Suzhou Abogen Biosciences Co., Ltd. |
Nucleic acid vaccines for coronavirus
|